相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Measurements of EGFR expression on circulating tumor cells are reproducible over time in metastatic breast cancer patients
Rachel E. Payne et al.
PHARMACOGENOMICS (2009)
Detection of circulating tumour cells in peripheral blood with an automated scanning fluorescence microscope
T. G. Ntouroupi et al.
BRITISH JOURNAL OF CANCER (2008)
Is there a role for circulating tumor cells in the management of breast cancer?
Daniel F. Hayes et al.
CLINICAL CANCER RESEARCH (2008)
Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer
Jeffrey A. Engelman et al.
CLINICAL CANCER RESEARCH (2008)
KRAS mutations predict response to EGFR inhibitors
Mitch Raponi et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer
Steven J. Cohen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Detection of mutations in EGFR in circulating lung-cancer cells
Shyamala Maheswaran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients
Glenn Deng et al.
BREAST CANCER RESEARCH (2008)
Isolation of rare circulating tumour cells in cancer patients by microchip technology
Sunitha Nagrath et al.
NATURE (2007)
Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer
Daniel C. Danila et al.
CLINICAL CANCER RESEARCH (2007)
Different prognostic value of cytokeratin-19 mRNA-positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer
Michail Ignatiadis et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer
David R. Shaffer et al.
CLINICAL CANCER RESEARCH (2007)
Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status
Tanja Fehm et al.
BREAST CANCER RESEARCH (2007)
Quantitative real-time RT-PCR of disseminated tumor cells in combination with immunomagnetic cell enrichment
Silke Lankiewicz et al.
MOLECULAR BIOTECHNOLOGY (2006)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
HER-2 gene amplification can be acquired as breast cancer progresses
SD Meng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: Evaluation of their prognostic significance
A Stathopoulou et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)